Grifols SA (GRFS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

GRFS is expected to report earnings to rise 175.92% to 23 cents per share on November 07

Q3'24

Est.

$0.24

Q2'24

Est.

$0.09

Q1'24

Missed

by $0.07

Q4'23

Est.

$0.23

Q3'23

Beat

by $0.02

The last earnings report on July 30 showed earnings per share of 8 cents, meeting the estimate of 8 cents. With 455.38K shares outstanding, the current market capitalization sits at 5.48B.

View a ticker or compare two or three

Compare

GRFS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GRFS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GRFS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of plasma-derived biological medicines

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

Avinguda de la Generalitat, 152

Phone

+34 935712200

Employees

23744

Web

https://www.grifols.com